Filter
940
Filtered Results: 940
Text search:
Pharmaceuticals
and
Supply
Agency
Featured
Recommendations
88
New Publications
292
Language
Document type
No document type
525
Studies & Reports
172
Guidelines
123
Strategic & Response Plan
52
Manuals
44
Training Material
9
Situation Updates
7
Fact sheets
5
Resource Platforms
3
Countries / Regions
Ethiopia
64
Kenya
42
Global
34
Nigeria
33
India
30
Liberia
25
Western and Central Europe
23
Uganda
21
Sierra Leone
18
Malawi
17
Ghana
16
Zambia
16
Bangladesh
16
Ukraine
16
Tanzania
15
Nepal
13
Syria
13
Namibia
13
Rwanda
12
Philippines
11
Indonesia
11
South Africa
10
Myanmar / Burma
10
Zimbabwe
9
Cambodia
9
Eastern Europe
9
Africa
8
South–East Asia Region
7
Congo, Democratic Republic of
6
Eswatini/ Swaziland
6
Botswana
6
Lesotho
6
Guinea
5
Senegal
5
South Sudan
5
Eastern Europe and Central Asia
5
Burkina Faso
4
Haiti
4
Papua New Guinea
4
East and Southern Africa
4
West and Central Africa
4
Latin America and the Carribbean
4
Pakistan
3
Mozambique
3
Sudan
3
Benin
3
North Macedonia
3
Asia
3
Venezuela
3
Cameroon
2
Iraq
2
Jordan
2
Afghanistan
2
Lebanon
2
Middle East and North Africa
2
Albania
2
Laos
2
Tajikistan
2
Moldova
2
Jamaica
2
United Kingdom
2
Mali
1
USA
1
Niger
1
Somalia
1
Egypt
1
Chad
1
Thailand
1
Central African Republic
1
Brazil
1
Serbia
1
Madagascar
1
Yemen
1
Palestine
1
Armenia
1
Russia
1
Bulgaria
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
Georgia
1
Gabon
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
450
Key Resources
52
Clinical Guidelines
49
Public Health
35
Women & Child Health
22
Pharmacy & Technologies
21
Capacity Building
9
Toolboxes
Pharmacy
83
AMR
76
COVID-19
61
TB
46
HIV
39
Conflict
30
Rapid Response
30
Mental Health
29
Planetary Health
26
NTDs
16
Global Health Education
15
Caregiver
13
Ebola
12
Specific Hazards
11
Health Financing Toolbox
11
Refugee
9
NCDs
9
Natural Hazards
8
Polio
4
Disability
3
Cholera
2
South Sudan
1
Zika
1
Social Ethics
1
Thefirst report on Latin America and the Carribean presents key indicators on health and health systems in 33 Latin America and the Caribbean coun...
This guide is available in English, French, Spanish, Russian, Arabic and Chinese
This guide consolidates COVID-19 guidance for human resources for health managers and policy-makers at national, sub...
5th edition.
Climate change is damaging human health now and is projected to have a greater impact in the future. Low- and middle-income countries are seeing the worst effects as they are most vulnerable to clim...
WHO Guidance for Climate Resilient and Environmentally Sustainable Health Care Facilities
recommended
The aim of this guidance is to enhance the capacity of health care facilities to protect and improve the health of their target communities in an unstable and changing climate; ... to empower health care facilities to be environmentally sustainable, by optimizing the use of resources and minimizing the release of waste into the environment. Climate resilient and environmentally sustainable health care facilities contribute to high quality of care and accessibility of services, and by helping reduce facility costs also ensure better affordability. They are, therefore, an important component of universal health coverage (UHC).
Structural, Non-structural and Functional Indicators
Consultancy Report May 2022
Disaster planning - organization and administration. 2.Emergency medical services - methods. 3.Emergency medical services - organization and administration. 4.Emergencies. 5.Health policy. 6.Health ...
This document should be used in conjunction with the WHO checklist for influenza preparedness planning published by the World Health Organization in 2005. Available in English; Chinese; French
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) ... non-traditional antibacterial agents in development worldwide. It evaluates to what extent the present pipeline addresses infections caused by WHO Priority Pathogens, Mycobacterium tuberculosis and Clostridioides difficile. The report also provides an assessment of the traditional agents with respect to whether they meet a set of predefined criteria for innovation, namely absence of known cross-resistance, new target, mode of action and/or class. It also includes an overview of the agents that obtained authorization since 1 July 2017.
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, howeve...
The health of the people and health services are in crisis, and together as partners this plan commits us to strategies aimed at achieving our goal of:
Strengthened primary health care for all,...
Strengthened primary health care for all,...
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national heal...
